Kaushik Guha

The combination of atrioventricular (AV) block – specifically high-grade AV block– within the setting of myocarditis, is a rarely encountered clinical phenomenon. It is commonly encountered in infiltrative cardiomyopathies but may be associated with myocarditis. Beyond conventional investigation and consideration of endomyocardial biopsy, there is a paucity of data to guide clinicians with regards to the issue of heart rhythm disorder.

Intravenous iron therapy in outcome trials in patients with heart failure To date, three large trials have assessed the effect of intravenous iron versus placebo or standard care on hospitalisations and mortality in patients with heart failure (table 2).

Heart Failure, Systolic Pharmacology, Clinical Biomarkers I keep six honest serving-men (They taught me all I knew); Their names are What and Why and When and How and Where and Who. - Rudyard Kipling Introduction Iron deficiency and anaemia, alone or in combination, are common in patients with heart failure and associated with increased risk of cardiovascular hospitalisation and death.1–3 The WHO4 defines anaemia as a haemoglobin <120 g/L for women and <130 g/L for men.